Target intelligence / Profile preview

Sulfated cell-surface proteoglycan (HSPG)

Target
HSPG
Molecular classification
Receptor, Glycoprotein, Extracellular matrix component
01

Overview

Sulfated cell-surface proteoglycans, most notably heparan sulfate proteoglycans (HSPGs) such as syndecans and glypicans, are complex glycoproteins characterized by a core protein attached to sulfated glycosaminoglycan (GAG) chains. These molecules are ubiquitous on the plasma membrane of animal cells, where they serve as critical regulators of the cellular microenvironment by binding a vast array of ligands, including growth factors, cytokines, and extracellular matrix proteins (Sarrazin et al., 2011, Cold Spring Harb Perspect Biol). By acting as co-receptors, they facilitate the formation of signaling complexes, thereby modulating pathways involved in cell proliferation, migration, and differentiation. In the context of infectious disease, many viruses and bacteria utilize these sulfated chains as initial attachment factors to concentrate on the cell surface before engaging specific entry receptors (Clausen et al., 2020, Cell). In oncology, dysregulation of these proteoglycans or their modifying enzymes, such as heparanase, promotes tumor angiogenesis and metastasis by releasing sequestered growth factors (Knelson et al., 2014, Nat Rev Cancer). Consequently, they are targeted by heparin mimetics and small molecules designed to disrupt these interactions or inhibit their degradation, offering therapeutic potential in cancer and viral infections (Hammond et al., 2014, Glycobiology).

Other names
Heparan sulfate proteoglycanCell-surface HSPGSyndecanGlypicanChondroitin sulfate proteoglycanCell-surface GAG
02

Mechanism of action

Competitive inhibition of ligand binding to glycosaminoglycan chains and inhibition of heparanase-mediated degradation of the extracellular matrix.

03

Biological functions

Signal transductionCell adhesionGrowth factor sequestrationViral attachmentCell proliferationAngiogenesis
04

Disease associations

CancerInfectionInflammationCardiovascular diseaseNeurodegenerative disease
05

Safety considerations

Anticoagulant activityOff-target growth factor inhibitionBleeding riskThrombocytopenia
06

Interacting drugs

Heparin

5 more in the full profile.

07

Biomarkers

Syndecan-1 (CD138)Glypican-3 (GPC3)Heparanase (HPSE)Soluble heparan sulfate

Beyond the preview

Go deeper on Sulfated cell-surface proteoglycan (HSPG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sulfated cell-surface proteoglycan (HSPG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call